Celltrion
068270.KS
$129.25
Share price
-1.17%
Change (1 day)
3.19%
Change (1 year)
Categories
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.
Celltrion (068270.KS) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $2.15 B
According to Celltrion 's latest financial reports the company's total liabilities are $2.15 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Celltrion - Total liabilities on balance sheet (from 2007 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $1.28 B | -6% |
| 2021-12-31 | $1.36 B | -6.91% |
| 2020-12-31 | $1.46 B | 71.78% |
| 2019-12-31 | $0.85 B | 4.92% |
| 2018-12-31 | $0.81 B | -1.88% |
| 2017-12-31 | $0.82 B | 21.4% |
| 2016-12-31 | $0.68 B | -14.48% |
| 2015-12-31 | $0.79 B | -10.28% |
| 2014-12-31 | $0.88 B | 5.24% |
| 2013-12-31 | $0.84 B | 28.55% |
| 2012-12-31 | $0.65 B | 50.18% |
| 2011-12-31 | $0.43 B | 31.43% |
| 2010-12-31 | $0.33 B | 40.23% |
| 2009-12-31 | $0.23 B | 5.59% |
| 2008-12-31 | $0.22 B | 497.84% |
| 2007-12-31 | $37.64 M |